Repaglinide D5

Modify Date: 2024-01-05 19:38:00

Repaglinide D5 structure	Common Name	Repaglinide D5
	CAS Number	1217709-85-7	Molecular Weight	457.61700
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₇H₃₁D₅N₂O₄	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Repaglinide D5

Repaglinide D5 (AG-EE 623ZW D5) is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1].

Name	4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]-2-(1,1,2,2,2-pentadeuterioethoxy)benzoic acid
Synonym	More Synonyms

Description	Repaglinide D5 (AG-EE 623ZW D5) is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Metabolic Disease
In Vitro	Repaglinide reduces postprandial glucose levels by enhancing the early phase of insulin secretion and increasing the total amount of insulin secreted[1].
References	[1]. Wang LC, et al. Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus.Medicine (Baltimore). 2018 Sep;97(38):e12476.

Molecular Formula	C₂₇H₃₁D₅N₂O₄
Molecular Weight	457.61700
Exact Mass	457.29900
PSA	82.36000
LogP	6.12520
Storage condition	-20°C

[2H5]-Repaglinide

Repaglinide-ethyl-d5